Audentes Therapeutics, Inc. Capital Expenditures
Audentes Therapeutics, Inc. reported Capital Expenditures of $10.02 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2019-11-07
- Audentes Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-09-30 was $4.38M, a 61.83% increase year-over-year.
- Audentes Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $4.35M, a 2.16% decline year-over-year.
- Audentes Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-03-31 was $1.29M, a 39.85% increase year-over-year.
- Audentes Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2018-12-31 was $3.54M, a 40.28% increase year-over-year.
- Audentes Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2018 was $11.61M, a 53.74% increase from fiscal 2017.
- Audentes Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2017 was $7.55M, a 54.65% decline from fiscal 2016.
- Audentes Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2016 was $16.65M, a 887.60% increase from fiscal 2015.
- Audentes Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2015 was $1.69M, a 1248.80% increase from fiscal 2014.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2019-09-30 | $4.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $8.73M derived: sum of 2 quarters · filed 2019-11-07 | $10.02M 10-Q · filed 2019-11-07 | $13.55M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $5.64M 10-Q · filed 2019-08-07 | $9.18M derived: sum of 3 quarters · filed 2019-08-07 | $11.88M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | $1.29M 10-Q · filed 2019-05-08 | $4.82M derived: sum of 2 quarters · filed 2019-05-08 | $7.53M derived: sum of 3 quarters · filed 2019-11-07 | $11.98M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $6.24M derived: sum of 2 quarters · filed 2019-11-07 | $10.69M derived: sum of 3 quarters · filed 2019-11-07 | $11.61M 10-K · filed 2019-03-01 |
| 2018-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $7.15M derived: sum of 2 quarters · filed 2019-11-07 | $8.07M 10-Q · filed 2019-11-07 | $10.59M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $4.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $5.37M 10-Q · filed 2019-08-07 | $7.89M derived: sum of 3 quarters · filed 2019-08-07 | $10.70M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $921.00K 10-Q · filed 2019-05-08 | $3.44M derived: sum of 2 quarters · filed 2019-05-08 | $6.25M derived: sum of 3 quarters · filed 2019-05-08 | $7.72M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $5.33M derived: sum of 2 quarters · filed 2019-03-01 | $6.80M derived: sum of 3 quarters · filed 2019-03-01 | $7.55M 10-K · filed 2019-03-01 |
| 2017-09-30 | $2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $4.28M derived: sum of 2 quarters · filed 2018-11-07 | $5.03M 10-Q · filed 2018-11-07 | $7.33M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.22M 10-Q · filed 2018-08-07 | $4.51M derived: sum of 3 quarters · filed 2019-03-01 | $10.02M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $752.00K 10-Q · filed 2018-05-10 | $3.05M derived: sum of 2 quarters · filed 2019-03-01 | $8.56M derived: sum of 3 quarters · filed 2019-03-01 | $15.26M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $7.81M derived: sum of 2 quarters · filed 2019-03-01 | $14.51M derived: sum of 3 quarters · filed 2019-03-01 | $16.65M 10-K · filed 2019-03-01 |
| 2016-09-30 | $5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $12.21M derived: sum of 2 quarters · filed 2017-11-14 | $14.36M 10-Q · filed 2017-11-14 | $15.18M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $8.85M 10-Q · filed 2017-08-10 | $9.67M derived: sum of 3 quarters · filed 2018-03-09 | $10.34M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $2.15M 10-Q · filed 2017-05-11 | $2.97M derived: sum of 2 quarters · filed 2018-03-09 | $3.64M derived: sum of 3 quarters · filed 2018-03-09 | |
| 2015-12-31 | $826.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.50M derived: sum of 2 quarters · filed 2018-03-09 | $1.69M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $669.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $860.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $191.00K 10-Q · filed 2016-09-01 | |||
| 2014-12-31 | $125.00K 10-K · filed 2017-03-13 |